In our study, caveolin-1 expression varied in different breast cancer cell lines: triple negative MDA-MB-231 cells showed the greatest caveolin-1 expression, while HER-2 positive SKBR-3 and BT-474 cells showed relatively moderate and lower caveolin-1 expressions, respectively. The gene discussed is ERBB2; the disease is breast cancer.